-
Something wrong with this record ?
Flavonoids against the SARS-CoV-2 induced inflammatory storm
A. Liskova, M. Samec, L. Koklesova, SM. Samuel, K. Zhai, RK. Al-Ishaq, M. Abotaleb, V. Nosal, K. Kajo, M. Ashrafizadeh, A. Zarrabi, A. Brockmueller, M. Shakibaei, P. Sabaka, I. Mozos, D. Ullrich, R. Prosecky, G. La Rocca, M. Caprnda, D....
Language English Country France
Document type Journal Article, Review
- MeSH
- Anti-Inflammatory Agents pharmacology therapeutic use MeSH
- COVID-19 immunology MeSH
- COVID-19 Drug Treatment MeSH
- Flavonoids pharmacology therapeutic use MeSH
- Humans MeSH
- SARS-CoV-2 * MeSH
- Cytokine Release Syndrome drug therapy immunology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
The disease severity of COVID-19, especially in the elderly and patients with co-morbidities, is characterized by hypercytokinemia, an exaggerated immune response associated with an uncontrolled and excessive release of proinflammatory cytokine mediators (cytokine storm). Flavonoids, important secondary metabolites of plants, have long been studied as therapeutic interventions in inflammatory diseases due to their cytokine-modulatory effects. In this review, we discuss the potential role of flavonoids in the modulation of signaling pathways that are crucial for COVID-19 disease, particularly those related to inflammation and immunity. The immunomodulatory ability of flavonoids, carried out by the regulation of inflammatory mediators, the inhibition of endothelial activation, NLRP3 inflammasome, toll-like receptors (TLRs) or bromodomain containing protein 4 (BRD4), and the activation of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2), might be beneficial in regulating the cytokine storm during SARS-CoV-2 infection. Moreover, the ability of flavonoids to inhibit dipeptidyl peptidase 4 (DPP4), neutralize 3-chymotrypsin-like protease (3CLpro) or to affect gut microbiota to maintain immune response, and the dual action of angiotensin-converting enzyme 2 (ACE-2) may potentially also be applied to the exaggerated inflammatory responses induced by SARS-CoV-2. Based on the previously proven effects of flavonoids in other diseases or on the basis of newly published studies associated with COVID-19 (bioinformatics, molecular docking), it is reasonable to assume positive effects of flavonoids on inflammatory changes associated with COVID-19. This review highlights the current state of knowledge of the utility of flavonoids in the management of COVID-19 and also points to the multiple biological effects of flavonoids on signaling pathways associated with the inflammation processes that are deregulated in the pathology induced by SARS-CoV-2. The identification of agents, including naturally occurring substances such as flavonoids, represents great approach potentially utilizable in the management of COVID-19. Although not clinically investigated yet, the applicability of flavonoids against COVID-19 could be a promising strategy due to a broad spectrum of their biological activities.
Biomedical Research Centre Slovak Academy of Sciences Bratislava Slovakia
Department of Functional Sciences Victor Babes University of Medicine and Pharmacy Timisoara Romania
Department of Leadership Faculty of Military Leadership University of Defence Brno Czech Republic
Department of Pathology St Elizabeth Cancer Institute Hospital Bratislava Slovakia
Faculty of Engineering and Natural Sciences Sabanci University Orta Mahalle Tuzla Istanbul Turkey
Faculty of Medicine University of Oviedo and Central University Hospital of Asturias Oviedo Spain
Sabanci University Nanotechnology Research and Application Center Tuzla Istanbul Turkey
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21018486
- 003
- CZ-PrNML
- 005
- 20220617104223.0
- 007
- ta
- 008
- 210728s2021 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biopha.2021.111430 $2 doi
- 035 __
- $a (PubMed)33662680
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Liskova, Alena $u Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia
- 245 10
- $a Flavonoids against the SARS-CoV-2 induced inflammatory storm / $c A. Liskova, M. Samec, L. Koklesova, SM. Samuel, K. Zhai, RK. Al-Ishaq, M. Abotaleb, V. Nosal, K. Kajo, M. Ashrafizadeh, A. Zarrabi, A. Brockmueller, M. Shakibaei, P. Sabaka, I. Mozos, D. Ullrich, R. Prosecky, G. La Rocca, M. Caprnda, D. Büsselberg, L. Rodrigo, P. Kruzliak, P. Kubatka
- 520 9_
- $a The disease severity of COVID-19, especially in the elderly and patients with co-morbidities, is characterized by hypercytokinemia, an exaggerated immune response associated with an uncontrolled and excessive release of proinflammatory cytokine mediators (cytokine storm). Flavonoids, important secondary metabolites of plants, have long been studied as therapeutic interventions in inflammatory diseases due to their cytokine-modulatory effects. In this review, we discuss the potential role of flavonoids in the modulation of signaling pathways that are crucial for COVID-19 disease, particularly those related to inflammation and immunity. The immunomodulatory ability of flavonoids, carried out by the regulation of inflammatory mediators, the inhibition of endothelial activation, NLRP3 inflammasome, toll-like receptors (TLRs) or bromodomain containing protein 4 (BRD4), and the activation of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2), might be beneficial in regulating the cytokine storm during SARS-CoV-2 infection. Moreover, the ability of flavonoids to inhibit dipeptidyl peptidase 4 (DPP4), neutralize 3-chymotrypsin-like protease (3CLpro) or to affect gut microbiota to maintain immune response, and the dual action of angiotensin-converting enzyme 2 (ACE-2) may potentially also be applied to the exaggerated inflammatory responses induced by SARS-CoV-2. Based on the previously proven effects of flavonoids in other diseases or on the basis of newly published studies associated with COVID-19 (bioinformatics, molecular docking), it is reasonable to assume positive effects of flavonoids on inflammatory changes associated with COVID-19. This review highlights the current state of knowledge of the utility of flavonoids in the management of COVID-19 and also points to the multiple biological effects of flavonoids on signaling pathways associated with the inflammation processes that are deregulated in the pathology induced by SARS-CoV-2. The identification of agents, including naturally occurring substances such as flavonoids, represents great approach potentially utilizable in the management of COVID-19. Although not clinically investigated yet, the applicability of flavonoids against COVID-19 could be a promising strategy due to a broad spectrum of their biological activities.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika $x farmakologie $x terapeutické užití $7 D000893
- 650 _2
- $a COVID-19 $x imunologie $7 D000086382
- 650 _2
- $a syndrom uvolnění cytokinů $x farmakoterapie $x imunologie $7 D000080424
- 650 _2
- $a flavonoidy $x farmakologie $x terapeutické užití $7 D005419
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a farmakoterapie COVID-19 $7 D000093485
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Samec, Marek $u Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia
- 700 1_
- $a Koklesova, Lenka $u Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia
- 700 1_
- $a Samuel, Samson M $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar
- 700 1_
- $a Zhai, Kevin $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar
- 700 1_
- $a Al-Ishaq, Raghad Khalid $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar
- 700 1_
- $a Abotaleb, Mariam $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar
- 700 1_
- $a Nosal, Vladimir $u Department of Neurology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia
- 700 1_
- $a Kajo, Karol $u Department of Pathology, St. Elizabeth Cancer Institute Hospital, Bratislava, Slovakia; Biomedical Research Centre, Slovak Academy of Sciences, Bratislava, Slovakia
- 700 1_
- $a Ashrafizadeh, Milad $u Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Tuzla, Istanbul, Turkey; Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, Istanbul, Turkey
- 700 1_
- $a Zarrabi, Ali $u Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, Istanbul, Turkey
- 700 1_
- $a Brockmueller, Aranka $u Musculoskeletal Research Group and Tumor Biology, Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, Ludwig-Maximilian-University Munich, Munich, Germany
- 700 1_
- $a Shakibaei, Mehdi $u Musculoskeletal Research Group and Tumor Biology, Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, Ludwig-Maximilian-University Munich, Munich, Germany
- 700 1_
- $a Sabaka, Peter, $u Department of Infectiology and Geographical Medicine, Faculty Medicine, Comenius University and University Hospital, Bratislava, Slovakia $d 1984- $7 xx0129262
- 700 1_
- $a Mozos, Ioana $u Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania; Center for Translational Research and Systems Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania
- 700 1_
- $a Ullrich, David $u Department of Leadership, Faculty of Military Leadership, University of Defence, Brno, Czech Republic
- 700 1_
- $a Prosecký, Robert $u 2nd Department of Internal Medicine, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic $7 xx0274031
- 700 1_
- $a La Rocca, Giampiero $u Human Anatomy Section, Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo and Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy
- 700 1_
- $a Caprnda, Martin $u 1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia
- 700 1_
- $a Büsselberg, Dietrich $u Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar
- 700 1_
- $a Rodrigo, Luis $u Faculty of Medicine, University of Oviedo and Central University Hospital of Asturias (HUCA), Oviedo, Spain
- 700 1_
- $a Kruzliak, Peter $u 2nd Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic. Electronic address: peter.kruzliak@savba.sk
- 700 1_
- $a Kubatka, Peter $u Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia. Electronic address: peter.kubatka@uniba.sk
- 773 0_
- $w MED00005486 $t Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie $x 1950-6007 $g Roč. 138, č. - (2021), s. 111430
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33662680 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20220617104215 $b ABA008
- 999 __
- $a ok $b bmc $g 1689554 $s 1138932
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 138 $c - $d 111430 $e 20210225 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
- LZP __
- $a Pubmed-20210728
